<DOC>
	<DOCNO>NCT00224796</DOCNO>
	<brief_summary>The purpose study compare effectiveness Vacuum Assisted Closure® ( V.A.C.® ) Therapy moist wound therapy amputation wound diabetic foot . The primary objective determine effect V.A.C.® Therapy incidence complete wound closure . Secondary objective include evaluate acceleration wound closure , facilitation surgical closure , incidence foot salvage , incidence wound complication .</brief_summary>
	<brief_title>Trial Vacuum Assisted Closure® Therapy Amputation Wounds Diabetic Foot</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Foot</mesh_term>
	<criteria>1 . Presence diabetic foot amputation wound transmetatarsal region foot 2 . Evidence adequate perfusion one following affected extremity , ( within past 60 day ) : Dorsum transcutaneous oxygen test ( TcPO2 ) result ≥30 mmHg , Ankle brachial index ( ABIs ) result ≥0.7 ≤1.2 toe pressure result ≥30 mmHg , Doppler arterial waveform , triphasic biphasic ankle affect leg . 3 . Age ≥ 18 year age 4 . HbA1c ≤ 12 % ( collect within last 90 day . ) 5 . Evidence adequate nutrition one following : Lab result reflect PreAlbumin ≥16 mg/dl Albumin level ≥3 g/dl ( seven day prior study period ) , A nutritional consult do appropriate supplementation start . Proper documentation ( case report form ) CRFs need . 1 . Patients recognize active Charcot abnormality foot , evidence clinical symptom interfere either randomized treatment group 2 . Wounds result electrical , chemical , radiation burn , venous insufficiency 3 . Untreated infection cellulitis site target wind 4 . Presence untreated osteomyelitis 5 . Collagen vascular disease 6 . Malignancy wind 7 . Presence necrotic tissue wind 8 . Uncontrolled hyperglycemia 9 . Concomitant medication include ( washout period 30 day corticosteroid , immunosuppressive medication , chemotherapy ) 10 . Prior V.A.C.® therapy within 30 day . 11 . Current prior normothermic ( WarmUP® ) hyperbaric oxygen ( HBO ) therapy within 30 day . 12 . Current prior treatment recombinant autologous growth factor product within past 30 day . ( Examples : Regranex Procuren ) 13 . Current prior treatment skin dermal substitute dressing ( Examples : Apligraf , Dermagraft , Integra ) live cell capable produce growth factor ( Example : Oasis ) within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Wound closure</keyword>
	<keyword>Foot salvage</keyword>
	<keyword>Accelerated healing</keyword>
	<keyword>Amputation Wounds Diabetic Foot</keyword>
</DOC>